Infectious diarrhea is a major cause of morbidity and mortality, particularly for children in low- and middle-income countries. Cryptosporidium is a diarrheal pathogen for which there is no vaccine and current therapies are only partially effective. In this issue of the JCI, Gilchrist, Campo, and colleagues surveyed a large cohort of Bangladeshi children to profile antibody responses against an array of Cryptosporidium proteins. They discovered 233 proteins to which children developed antibodies, identified seven as being associated with protection from reinfection, and provided insights regarding the longevity of Cryptosporidium antibodies and the development of antibody breadth. In this commentary, we discuss the burden of disease caused by Cryptosporidium and how these studies highlight the strategies to better manage this parasite.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425208PMC
http://dx.doi.org/10.1172/JCI171966DOI Listing

Publication Analysis

Top Keywords

cryptosporidium antibodies
8
cryptosporidium
5
mining crypto
4
crypto protection
4
protection search
4
search cryptosporidium
4
antibodies reveals
4
reveals antigens
4
antigens associated
4
associated immunity
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!